Quarles & Brady 's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
- Penetration Testing In Healthcare: HIPAA And GDPR Requirements
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Supporting NASH/NAFLD's Unmet Needs With ePRO
Explore the rising prevalence of NASH/MASH, its debilitating effects, and the urgent need for patient-centric approaches in clinical research.
-
Mitigating The Risks Of Long-Term Oncology eCOA Clinical Trials
This article digs into the specific complexities of long oncology clinical trials and describes relevant solutions to manage the risks regarding patient compliance, clinical project teams, and clinical sites.
-
eCOA Solution Design Recommendations: Applied Insights From Trial Sites, CRAs
Enhance hybrid trials with digitalization through remote data capture using smartphones, tablets, and computers, improving participant experience and data integrity.
-
Revolutionizing Trial Supply Management With The Power Of Free Picking
Discover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.
-
Digital Medicine Society Accelerates Recruitment and Results With eConsent
Find out how the Digital Medicine Society (DiMe), an interdisciplinary professional society for digital medicine, was able to deploy an eConsent module in less than two weeks to support its remote study to assess nocturnal scratching as an endpoint for patients.
-
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers
Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
Case Study: How Real-World Data Optimized An Oncology Clinical Trial Protocol
Many challenges in running clinical trials are difficult to prepare for, but some, such as trial enrollment and study operational execution, can be proactively addressed thanks to advances in high-quality RWD.
-
Hidden Costs Of Data Cleaning: Build Quality At The Source
Hidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.
-
Clinical Research Data Management Can Be Easy, With A Little REST
Uncover how RESTful web services enable different systems to communicate effortlessly, breaking down traditional barriers and allowing for the flexible design of applications that can be accessed across various devices.
-
FDA Releases Updated Draft Guidance On Decentralized Clinical Trials
Take a closer look at the FDA's draft guidance on designing and implementing DCTs, notably remote trial visits, the use of digital health technologies, institutional review board oversight, and more.